BNTX vs PEN
BioNTech SE vs Penumbra, Inc. — AI-powered side-by-side comparison
VS
PEN
Penumbra, Inc.
67
Buy
| Metric | BNTX | PEN |
|---|
| AI Score |
66
|
67
|
| Price |
$92.76
|
$326.07
|
| P/E Ratio |
-11.76×
|
79.78×
|
| ROE |
-5.7%
|
12.4%
|
| Revenue Growth YoY |
—
|
—
|
| Gross Margin |
68.9%
|
67.8%
|
| Debt / Equity |
0.02×
|
0.14×
|
| Dividend Yield |
0.0%
|
0.0%
|
| RSI (14) |
54.0
|
79.6
|
| Beta |
1.278
|
0.701
|
| Expected Upside |
—
|
+6.3%
|
AI Committee View
Current Innellis committee reasoning for BNTX versus PEN.
PEN leads by 1 points.
PEN scores 67/100 (Buy) versus BNTX at 66/100 (Buy).
BNTX Committee View
50% agreement
4 analysts
The committee is split. Analysts see this stock differently enough that the current rating reflects genuine uncertainty, not a weak signal.
Bull Case
- MACD histogram positive -- bullish momentum — Technical
- VIX regime is low -- calm backdrop supports risk-taking — Macro
- Market regime is bullish (Bull market -- normal position sizing) — Macro
PEN Committee View
80% agreement
5 analysts
The primary driver is vix regime is low -- calm backdrop supports risk-taking. The main limiting factor is 2 consecutive earnings misses -- execution concerns. The committee is constructive but not yet at full conviction.
Bull Case
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- Price structure making higher highs and higher lows — Technical
- MACD histogram positive -- bullish momentum — Technical
Bear Case
- 2 consecutive earnings misses -- execution concerns — Growth
- RSI at 80 is in overbought territory — Technical